Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,773
Total Claims
$1.0M
Drug Cost
507
Beneficiaries
$2,024
Cost/Patient
Risk Score Breakdown 13/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+182%
Opioid rate vs peers
7.3% vs 2.6% avg
+90%
Cost per patient vs peers
$2,024 vs $1,068 avg
+40%
Brand preference vs peers
12.6% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
7.3%
Opioid Rate
710
Opioid Claims
$20K
Opioid Cost
2.0%
Long-Acting Rate
Brand vs Generic
Brand: 1,221 claims · $788K
Generic: 8,460 claims · $233K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 98 | $110K |
| Empagliflozin | 68 | $75K |
| Apixaban | 66 | $73K |
| Rivaroxaban | 77 | $68K |
| Semaglutide | 46 | $49K |
| Insulin Glargine,hum.Rec.Anlog | 58 | $43K |
| Lurasidone Hcl | 13 | $40K |
| Insulin Glargine,hum.Rec.Anlog | 16 | $21K |
| Budesonide/Formoterol Fumarate | 25 | $19K |
| Linagliptin | 13 | $15K |
| Linaclotide | 17 | $14K |
| Tirzepatide | 13 | $14K |
| Insulin Glargine,hum.Rec.Anlog | 15 | $13K |
| Tiotropium Bromide | 15 | $12K |
| Budesonide/Glycopyr/Formoterol | 15 | $11K |
Prescribing Profile
Patient Profile
72
Avg Age
55%
Female
1.27
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About